▁Sub 6.66015625
title 4.55078125
: 0.78369140625
▁Trade 8.9140625
▁Rest 7.7109375
rict 0.1474609375
ions 0.023681640625
▁and 1.8310546875
▁Market 4.26171875
▁Ch 5.51953125
alleng 1.880859375
es 0.0021839141845703125
▁A 4.234375
ffect 0.14599609375
▁Le 7.15234375
ading 2.267578125
▁Medical 7.25390625
▁Device 0.459716796875
▁Man 1.4853515625
ufact 0.0009059906005859375
urer 1.7236328125
' 2.345703125
s 0.0026264190673828125
▁Fin 3.4921875
an 0.1566162109375
cial 0.0017194747924804688
▁Performance 0.8173828125
▁ 7.015625
<0x0A> 6.31640625
Introduction 5.9140625
: 0.218017578125
<0x0A> 1.3740234375
In 2.955078125
▁a 3.568359375
▁quarter 6.8984375
▁marked 4.86328125
▁by 0.03546142578125
▁unexpected 5.6484375
▁hur 7.3125
d 0.00024580955505371094
les 0.0005249977111816406
, 0.9794921875
▁St 5.5625
. 0.084228515625
▁J 0.09661865234375
ude 0.002422332763671875
▁Medical 0.033966064453125
▁Inc 2.1484375
., 2.5234375
▁a 0.4560546875
▁leading 0.55712890625
▁global 2.150390625
▁medical 0.4306640625
▁device 0.106201171875
▁manufact 0.49658203125
urer 0.033355712890625
, 0.2763671875
▁reported 1.9453125
▁lower 2.951171875
- 0.9775390625
than 0.010650634765625
- 0.018646240234375
antic 2.564453125
ip 3.910064697265625e-05
ated 0.0003750324249267578
▁prof 3.65234375
its 0.0009255409240722656
▁due 3.6953125
▁to 0.148681640625
▁a 2.109375
▁missed 9.7578125
▁heart 12.9921875
▁val 1.5322265625
ve 0.0014677047729492188
▁sale 3.654296875
▁to 3.490234375
▁Iran 4.9453125
▁and 0.904296875
▁a 1.7880859375
▁combination 6.6015625
▁of 0.06927490234375
▁other 3.041015625
▁factors 0.888671875
. 0.275390625
▁Trade 8.109375
▁restrictions 0.36572265625
▁and 0.955078125
▁market 0.79638671875
▁challeng 0.149169921875
es 0.00046372413635253906
▁have 1.8935546875
▁played 5.05859375
▁a 0.2060546875
▁det 7.078125
r 0.0008563995361328125
iment 0.00023448467254638672
al 0.0004436969757080078
▁role 0.038238525390625
▁in 0.10076904296875
▁the 0.5791015625
▁company 0.263671875
' 0.2293701171875
s 0.0016126632690429688
▁financial 0.94140625
▁performance 0.12176513671875
, 1.4765625
▁highlight 4.10546875
ing 0.00844573974609375
▁the 0.100341796875
▁complex 4.37109375
ities 0.374267578125
▁faced 4.10546875
▁by 0.04168701171875
▁business 2.171875
es 0.0330810546875
▁in 1.5185546875
▁the 1.6181640625
▁medical 1.4375
▁industry 2.671875
. 0.2449951171875
<0x0A> 0.6123046875
Miss 7.16015625
ed 0.0230865478515625
▁Sales 3.419921875
▁O 1.8974609375
pport 0.0004482269287109375
unity 0.3017578125
▁in 1.05859375
▁Iran 0.017578125
: 0.2218017578125
<0x0A> 0.2440185546875
St 1.1337890625
. 0.0038585662841796875
▁J 0.0014171600341796875
ude 0.00011134147644042969
▁Medical 0.164306640625
▁Inc 1.3037109375
. 0.186279296875
▁had 2.568359375
▁been 1.6904296875
▁on 4.22265625
▁track 0.305419921875
▁for 2.541015625
▁a 0.382568359375
▁strong 2.54296875
▁third 3.96875
▁quarter 0.0771484375
▁until 2.16015625
▁an 2.56640625
▁un 2.517578125
for 0.63134765625
ese 0.0032024383544921875
en 0.0052490234375
▁set 3.8359375
back 0.0110626220703125
▁occurred 1.236328125
: 3.35546875
▁a 1.3212890625
▁missed 1.349609375
▁heart 1.791015625
▁val 0.0030364990234375
ve 3.707408905029297e-05
▁sale 0.01568603515625
▁to 0.2391357421875
▁Iran 0.07110595703125
. 0.1094970703125
▁The 0.58837890625
▁potential 4.76953125
▁deal 2.498046875
, 1.13671875
▁which 1.552734375
▁could 2.22265625
▁have 0.006702423095703125
▁significantly 5.54296875
▁boost 0.8564453125
ed 0.00020635128021240234
▁the 0.438720703125
▁company 0.01483917236328125
' 0.0171051025390625
s 1.4662742614746094e-05
▁reven 2.66796875
ues 9.202957153320312e-05
, 0.14208984375
▁was 0.217529296875
▁th 2.583984375
wart 1.52587890625e-05
ed 3.5762786865234375e-06
▁by 0.308349609375
▁trade 1.7109375
▁restrictions 0.11669921875
▁im 1.005859375
posed 3.4570693969726562e-06
▁on 1.34765625
▁Iran 0.41259765625
▁by 0.91650390625
▁the 0.0162200927734375
▁United 0.56005859375
▁States 0.0014886856079101562
, 3.09375
▁leaving 2.171875
▁St 0.55126953125
. 0.004993438720703125
▁J 0.001125335693359375
ude 3.0159950256347656e-05
▁Medical 0.72998046875
▁with 1.408203125
▁limited 6.15234375
▁options 0.262451171875
▁for 0.6005859375
▁growth 2.43359375
▁in 0.7197265625
▁the 0.376708984375
▁region 0.626953125
. 0.015533447265625
▁Despite 4.375
▁being 4.328125
▁a 1.3544921875
▁leading 1.837890625
▁player 2.0
▁in 0.00420379638671875
▁the 0.04437255859375
▁card 4.05078125
iac 1.2509765625
▁medical 2.2734375
▁device 0.1656494140625
▁sector 4.08203125
, 0.0224761962890625
▁the 0.71484375
▁firm 6.3984375
▁was 1.3671875
▁unable 0.310791015625
▁to 0.00012314319610595703
▁capital 0.53369140625
ize 0.0251312255859375
▁on 0.003253936767578125
▁a 2.349609375
▁market 5.01171875
▁with 1.8837890625
▁immense 3.64453125
▁potential 0.074951171875
▁due 0.60302734375
▁to 0.0019588470458984375
▁these 2.67578125
▁restrictions 0.6953125
. 0.173095703125
<0x0A> 0.2012939453125
Tra 2.330078125
de 0.0004000663757324219
▁Rest 0.38330078125
rict 0.003734588623046875
ions 0.0002117156982421875
▁and 1.216796875
▁Global 4.5625
▁Dynam 5.20703125
ics 0.0004930496215820312
: 0.060211181640625
<0x0A> 0.0195770263671875
Wh 2.791015625
ile 0.0003521442413330078
▁St 1.84375
. 0.005084991455078125
▁J 0.0005183219909667969
ude 2.002716064453125e-05
▁Medical 0.0162200927734375
' 1.294921875
s 8.988380432128906e-05
▁missed 0.765625
▁sale 0.56640625
▁in 0.92236328125
▁Iran 0.0012826919555664062
▁height 11.484375
ened 0.1644287109375
▁their 4.46484375
▁financial 1.6513671875
▁challeng 2.05078125
es 9.250640869140625e-05
, 0.10858154296875
▁they 2.92578125
▁also 2.7109375
▁symbol 7.5234375
ize 0.35107421875
▁the 0.80126953125
▁bro 1.1513671875
ader 1.2278556823730469e-05
▁problems 4.71484375
▁faced 1.025390625
▁by 0.005123138427734375
▁medical 1.490234375
▁supp 7.9140625
liers 0.00344085693359375
▁in 1.3369140625
▁a 2.076171875
▁dynamic 3.490234375
▁global 0.414794921875
▁market 0.321533203125
. 0.296142578125
▁The 1.5107421875
▁ge 6.015625
opol 0.0176239013671875
it 1.8835067749023438e-05
ical 0.0191650390625
▁landscape 1.185546875
, 2.564453125
▁san 6.671875
ctions 0.00783538818359375
, 0.2744140625
▁and 0.260498046875
▁trade 1.5029296875
▁reg 2.775390625
ulations 0.005947113037109375
▁continue 3.755859375
▁to 0.0018472671508789062
▁shape 2.21875
▁the 0.312255859375
▁medical 1.634765625
▁device 0.398193359375
▁industry 0.302490234375
, 0.5478515625
▁pos 3.84765625
ing 0.00023233890533447266
▁hur 4.015625
d 1.6689300537109375e-06
les 0.000377655029296875
▁that 2.556640625
▁are 2.904296875
▁difficult 0.60595703125
▁for 2.67578125
▁even 2.25
▁established 2.91796875
▁companies 0.986328125
▁to 0.3125
▁overcome 0.443603515625
. 0.0084991455078125
▁The 2.28125
▁market 4.92578125
▁dynamics 2.939453125
, 3.037109375
▁combined 2.876953125
▁with 0.0004189014434814453
▁string 5.31640625
ent 0.00036263465881347656
▁regul 1.1982421875
atory 0.00019061565399169922
▁environments 4.2421875
, 0.509765625
▁create 2.474609375
▁complex 3.318359375
▁obst 3.421875
acles 0.0003135204315185547
▁that 1.060546875
▁can 1.298828125
▁h 2.435546875
inder 0.0008339881896972656
▁growth 0.79052734375
▁opportun 3.2109375
ities 6.949901580810547e-05
▁and 0.724609375
▁impact 2.287109375
▁financial 1.1005859375
▁results 3.3828125
▁for 4.296875
▁companies 1.3955078125
▁like 1.509765625
▁St 0.00266265869140625
. 0.0087127685546875
▁J 0.0027484893798828125
ude 7.915496826171875e-05
▁Medical 0.01727294921875
. 0.19970703125
<0x0A> 0.046417236328125
Comp 4.42578125
et 0.177490234375
itive 1.2265625
▁Land 1.05859375
s 0.0031757354736328125
cape 1.5616416931152344e-05
▁and 0.6630859375
▁Techn 4.609375
ological 0.00850677490234375
▁Ad 1.0107421875
van 0.0001327991485595703
c 0.045196533203125
ements 5.125999450683594e-06
: 0.0227203369140625
<0x0A> 0.004547119140625
The 1.275390625
▁medical 0.7529296875
▁device 0.053619384765625
▁industry 0.1534423828125
▁is 0.132568359375
▁highly 0.8505859375
▁compet 0.0097198486328125
itive 3.516674041748047e-05
, 0.1845703125
▁with 0.33349609375
▁constant 5.1484375
▁adv 1.5205078125
anc 0.0841064453125
ements 6.556510925292969e-06
▁pushing 7.0390625
▁companies 0.45263671875
▁to 0.0228271484375
▁innov 0.4619140625
ate 0.0002810955047607422
▁and 0.205322265625
▁stay 1.8720703125
▁ahead 0.076416015625
. 2.474609375
▁During 8.5
▁the 0.330322265625
▁third 0.728515625
▁quarter 0.005672454833984375
, 0.2132568359375
▁St 0.27880859375
. 0.0033054351806640625
▁J 0.0010080337524414062
ude 4.112720489501953e-05
▁Medical 0.0166168212890625
▁faced 1.1083984375
▁st 1.58203125
iff 0.0226593017578125
▁competition 0.007598876953125
▁from 0.173583984375
▁rival 3.04296875
▁manufact 1.923828125
ur 0.004364013671875
ers 2.2649765014648438e-06
, 0.623046875
▁many 3.65234375
▁of 0.0215301513671875
▁whom 0.37646484375
▁introduced 4.71875
▁new 0.17138671875
▁products 0.295166015625
▁and 0.8330078125
▁techn 0.82470703125
ologies 0.021697998046875
. 1.90234375
▁These 1.82421875
▁innov 2.47265625
ations 0.0237274169921875
▁not 3.076171875
▁only 0.000408172607421875
▁required 5.828125
▁St 2.68359375
. 0.0022678375244140625
▁J 0.001171112060546875
ude 4.279613494873047e-05
▁Medical 0.047149658203125
▁to 0.005695343017578125
▁improve 3.962890625
▁their 0.5498046875
▁offer 1.1298828125
ings 1.8358230590820312e-05
▁but 0.62060546875
▁also 0.021514892578125
▁necess 3.380859375
itated 0.012603759765625
▁significant 1.9140625
▁invest 0.2734375
ments 0.207275390625
▁in 0.2296142578125
▁research 0.1697998046875
▁and 0.01025390625
▁development 0.0006222724914550781
▁to 2.390625
▁maintain 1.876953125
▁a 1.3056640625
▁compet 0.0802001953125
itive 9.298324584960938e-05
▁edge 0.054718017578125
. 0.050018310546875
▁However 4.3046875
, 0.00015306472778320312
▁bal 8.734375
ancing 0.006534576416015625
▁the 1.609375
▁pressure 4.44140625
▁to 0.3935546875
▁innov 0.280517578125
ate 0.00012958049774169922
▁and 1.2294921875
▁remain 3.37109375
▁cost 3.533203125
- 0.0106964111328125
comp 3.291015625
et 1.5854835510253906e-05
itive 0.0001442432403564453
▁proved 5.5
▁challeng 0.5810546875
ing 3.0159950256347656e-05
▁for 1.10546875
▁the 0.2373046875
▁company 0.1671142578125
, 0.6591796875
▁further 3.109375
▁impact 0.69189453125
ing 7.998943328857422e-05
▁their 0.294189453125
▁prof 4.71875
its 0.0003457069396972656
. 0.12890625
<0x0A> 0.0165863037109375
CO 6.74609375
VID 0.1041259765625
- 0.035980224609375
1 0.005218505859375
9 0.00045490264892578125
▁Pan 1.048828125
demic 0.00019407272338867188
▁and 0.45068359375
▁Hospital 6.77734375
▁Bud 3.7890625
get 0.273681640625
▁Con 3.740234375
stra 0.00054168701171875
ints 0.00823974609375
: 0.01229095458984375
<0x0A> 0.0030345916748046875
An 2.0390625
other 0.049530029296875
▁factor 0.55078125
▁contrib 1.4267578125
uting 1.7881393432617188e-06
▁to 0.00045871734619140625
▁St 0.07666015625
. 0.0016927719116210938
▁J 0.0007534027099609375
ude 2.47955322265625e-05
▁Medical 0.0098876953125
' 0.01514434814453125
s 9.453296661376953e-05
▁third 4.21875
- 0.335205078125
qu 0.00019609928131103516
arter 2.0265579223632812e-06
▁strugg 2.138671875
les 5.1140785217285156e-05
▁was 0.06243896484375
▁the 0.060302734375
▁on 1.1435546875
going 0.006855010986328125
▁COVID 0.326904296875
- 0.0007724761962890625
1 0.0001977682113647461
9 0.000293731689453125
▁pan 0.005855560302734375
demic 1.8596649169921875e-05
. 0.47998046875
▁H 2.6328125
osp 0.0002307891845703125
it 1.0728836059570312e-06
als 7.152557373046875e-07
▁glob 6.0625
ally 3.5643577575683594e-05
▁faced 1.642578125
▁significant 1.4814453125
▁financial 1.5185546875
▁press 1.9775390625
ures 1.52587890625e-05
▁due 0.8466796875
▁to 0.0002808570861816406
▁increased 3.35546875
▁health 2.015625
care 0.047119140625
▁exp 1.0322265625
end 0.693359375
iture 0.99365234375
▁and 0.982421875
▁reduced 1.333984375
▁patient 0.8349609375
▁volumes 0.5458984375
. 0.97265625
▁This 0.91748046875
, 2.927734375
▁in 0.75439453125
▁turn 0.0205230712890625
, 5.888938903808594e-05
▁led 1.505859375
▁to 0.037200927734375
▁budget 1.109375
▁constraints 0.2215576171875
▁and 1.35546875
▁delayed 2.662109375
▁or 2.28515625
▁can 0.82275390625
ce 0.00010478496551513672
led 2.0265579223632812e-05
▁medical 1.375
▁device 0.345458984375
▁purch 0.281494140625
ases 0.004482269287109375
, 0.380859375
▁affect 2.28125
ing 1.52587890625e-05
▁St 0.78662109375
. 0.0018863677978515625
▁J 0.0010061264038085938
ude 5.984306335449219e-05
▁Medical 0.0197906494140625
' 0.0540771484375
s 6.389617919921875e-05
▁profit 4.890625
ability 0.07379150390625
. 0.091552734375
▁The 1.6865234375
▁uncertainty 5.6015625
▁surrounding 1.322265625
▁the 0.047210693359375
▁pan 0.137939453125
demic 4.279613494873047e-05
▁and 0.9677734375
▁its 0.41455078125
▁impact 0.91943359375
▁on 0.033111572265625
▁the 0.59619140625
▁health 1.76953125
care 0.00534820556640625
▁industry 0.640625
▁remains 3.40234375
▁a 0.153564453125
▁key 3.240234375
▁challenge 1.0556640625
▁for 0.09674072265625
▁medical 1.1279296875
▁device 0.24267578125
▁manufact 0.366943359375
ur 0.0016155242919921875
ers 1.1920928955078125e-07
. 1.3798828125
<0x0A> 0.0562744140625
Con 2.8125
clusion 0.11419677734375
: 0.032257080078125
<0x0A> 5.4375
St 2.48828125
. 0.0016994476318359375
▁J 0.0008101463317871094
ude 1.4662742614746094e-05
▁Medical 0.0016803741455078125
▁Inc 1.349609375
. 1.0341796875
▁faced 1.4658203125
▁notable 7.92578125
▁challeng 0.8828125
es 2.1219253540039062e-05
▁that 5.0390625
▁impact 0.74560546875
ed 0.001384735107421875
▁their 0.1474609375
▁third 1.7392578125
- 0.059661865234375
qu 0.00021958351135253906
arter 1.33514404296875e-05
▁prof 2.458984375
its 7.510185241699219e-05
, 1.2548828125
▁including 1.1884765625
▁a 1.0078125
▁missed 0.0579833984375
▁heart 1.1826171875
▁val 0.00130462646484375
ve 1.6927719116210938e-05
▁sale 0.00665283203125
▁to 0.397216796875
▁Iran 0.0011396408081054688
▁due 3.515625
▁to 0.00022470951080322266
▁trade 0.05413818359375
▁restrictions 0.01025390625
, 0.412109375
▁increasing 4.15234375
▁competition 0.1807861328125
, 0.64453125
▁the 4.09765625
▁COVID 0.7607421875
- 0.0018205642700195312
1 0.0005350112915039062
9 3.2186508178710938e-06
▁pan 0.002086639404296875
demic 8.344650268554688e-05
, 0.1942138671875
▁and 0.01279449462890625
▁hosp 6.94140625
it 0.0002372264862060547
als 2.0503997802734375e-05
' 0.34716796875
▁budget 0.260986328125
▁constraints 0.0474853515625
. 0.02130126953125
▁As 3.587890625
▁the 0.46142578125
▁world 3.306640625
▁trans 5.37109375
itions 0.0018892288208007812
▁into 2.236328125
▁a 0.319580078125
▁post 0.53466796875
- 0.0017852783203125
pan 0.0870361328125
demic 1.1563301086425781e-05
▁era 0.28271484375
, 0.032257080078125
▁it 2.556640625
▁is 0.87890625
▁cru 1.5087890625
cial 9.894371032714844e-06
▁for 0.109130859375
▁medical 0.498291015625
▁device 0.040252685546875
▁manufact 0.2440185546875
ur 0.0032863616943359375
ers 1.1920928955078125e-07
▁and 4.609375
▁polic 7.1875
ym 6.198883056640625e-06
akers 9.191036224365234e-05
▁to 0.046966552734375
▁navigate 2.41796875
▁these 1.439453125
▁challeng 2.01171875
es 0.03118896484375
▁collabor 5.609375
atively 0.00014150142669677734
. 2.658203125
▁St 3.05859375
rik 6.3671875
ing 5.8531761169433594e-05
▁a 0.32470703125
▁balance 0.0175018310546875
▁between 0.00713348388671875
▁ens 4.875
uring 1.9788742065429688e-05
▁patient 1.1787109375
▁safety 1.134765625
, 0.93994140625
▁prom 1.919921875
oting 3.3736228942871094e-05
▁innov 0.20068359375
ation 0.008514404296875
, 0.080078125
▁and 0.0548095703125
▁maintain 1.13671875
ing 0.00015079975128173828
▁a 2.189453125
▁compet 0.623046875
itive 0.0005283355712890625
▁market 2.296875
▁will 1.724609375
▁be 0.2144775390625
▁essential 0.95263671875
▁for 0.44384765625
▁sust 2.783203125
ained 1.5908203125
▁growth 0.1883544921875
▁in 0.93310546875
▁the 0.10601806640625
▁medical 0.60107421875
▁industry 2.630859375
. 0.045623779296875
